BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6933255)

  • 1. Reassessment of cancer predisposition of Fanconi anemia heterozygotes.
    Swift M; Caldwell RJ; Chase C
    J Natl Cancer Inst; 1980 Nov; 65(5):863-7. PubMed ID: 6933255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in Fanconi anemia, 1927-2001.
    Alter BP
    Cancer; 2003 Jan; 97(2):425-40. PubMed ID: 12518367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and autoimmune disease in families with common variable immune deficiency.
    Morrell D; Chase CL; Swift M
    Genet Epidemiol; 1986; 3(1):17-26. PubMed ID: 3957001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.
    Pagano G; Degan P; d'Ischia M; Kelly FJ; Pallardó FV; Zatterale A; Anak SS; Akisik EE; Beneduce G; Calzone R; De Nicola E; Dunster C; Lloret A; Manini P; Nobili B; Saviano A; Vuttariello E; Warnau M
    Carcinogenesis; 2004 Oct; 25(10):1899-909. PubMed ID: 15192013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer in families with severe combined immune deficiency.
    Morrell D; Chase CL; Swift M
    J Natl Cancer Inst; 1987 Mar; 78(3):455-8. PubMed ID: 3469459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus in ataxia-telangiectasia, Fanconi anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families.
    Morrell D; Chase CL; Kupper LL; Swift M
    Diabetes; 1986 Feb; 35(2):143-7. PubMed ID: 3943665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anaemia genes and susceptibility to cancer.
    Mathew CG
    Oncogene; 2006 Sep; 25(43):5875-84. PubMed ID: 16998502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant disease in heterozygous carriers.
    Swift M
    Birth Defects Orig Artic Ser; 1976; 12(1):133-44. PubMed ID: 990439
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial aggregation of breast cancer with early onset lung cancer.
    Schwartz AG; Siegfried JM; Weiss L
    Genet Epidemiol; 1999 Nov; 17(4):274-84. PubMed ID: 10520210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
    Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
    Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for smoking-related cancer among relatives of lung cancer patients.
    Etzel CJ; Amos CI; Spitz MR
    Cancer Res; 2003 Dec; 63(23):8531-5. PubMed ID: 14679021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi's anemia and malignancies.
    Alter BP
    Am J Hematol; 1996 Oct; 53(2):99-110. PubMed ID: 8892734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic assessment of Fanconi anemia in children with aplastic anemia in Tunisia.
    Talmoudi F; Kammoun L; Benhalim N; Torjemane L; Ouederni M; Aissaoui L; Lakhal A; Mellouli F; Othmen TB; Bejaoui M; Abdelhak S; Meddeb M; Dellagi K; Hdiji S; Amouri A;
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):547-50. PubMed ID: 23337544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular study of Fanconi anemia in Tunisia].
    Bouchlaka C; Abdelhak S; Dellagi K;
    Tunis Med; 2004 May; 82(5):402-10. PubMed ID: 15453041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Fanconi anemia from idiopathic aplastic anemia by induced chromosomal breakage study using mitomycin-C (MMC).
    Talwar R; Choudhry VP; Kucheria K
    Indian Pediatr; 2004 May; 41(5):473-7. PubMed ID: 15181297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage and repair of leukocytes from Fanconi anaemia patients, carriers and healthy individuals as measured by the alkaline comet assay.
    Mohseni-Meybodi A; Mozdarani H; Mozdarani S
    Mutagenesis; 2009 Jan; 24(1):67-73. PubMed ID: 18836100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.